1 Endocrinology, University Hospital of Pisa , Pisa, Italy .
Thyroid. 2014 Jan;24(1):60-6. doi: 10.1089/thy.2013.0240. Epub 2013 Dec 9.
According to Rundle's curve, Graves' ophthalmopathy (GO) worsens during an initial phase up to a peak of maximum severity, then improves and reaches a static plateau, with the activity curve preceding the severity curve by a few months. To our knowledge, no studies have tried to replicate Rundle's curve, and very few have investigated the natural history of GO. Here, we studied GO natural history retrospectively and tried to identify factors that may affect it.
A total of 65 patients with untreated GO underwent an eye assessment after a median of seven months after the appearance of GO and then after a median of 40 months. The primary endpoints were the variation of the single GO features and of the NOSPECS score, as well as the overall outcome of GO. The secondary endpoint was the influence of several variables (age, sex, smoking, GO and thyroid disease duration, thyroid treatment, thyroid status, thyroid volume, anti-TSH receptor autoantibodies) on the outcome of GO.
The majority of patients had mild, minimally active GO, and only five had a Clinical Activity Score (CAS) >3. There was a significant reduction of CAS (p<0.0001) and NOSPECS (p=0.01) between the first and last observation, with a timing pattern resembling Rundle's curve. This difference was confirmed even when patients with a CAS >3 at first observation were excluded. At the last observation, 50.8% of patients had improved, 33.8% had remained stable, and 15.4% had worsened moderately or substantially. The overall outcome of GO was not affected by any of the variables under examination.
In confirmation of Rundle's observations, untreated GO improves spontaneously with time in the majority of patients, with an activity peak between 13 and 24 months, which may have implications in determining the proper timing of GO treatments.
根据伦德尔曲线,格雷夫斯眼病(GO)在初始阶段会恶化,达到严重程度的峰值,然后改善并达到稳定的平台期,活动曲线比严重程度曲线提前几个月。据我们所知,尚未有研究试图复制伦德尔曲线,也很少有研究调查 GO 的自然史。在这里,我们回顾性地研究了 GO 的自然史,并试图确定可能影响其发展的因素。
65 例未经治疗的 GO 患者在出现 GO 后中位数 7 个月和中位数 40 个月后接受眼部评估。主要终点是单个 GO 特征和 NOSPECS 评分的变化,以及 GO 的总体结局。次要终点是几个变量(年龄、性别、吸烟、GO 和甲状腺疾病的持续时间、甲状腺治疗、甲状腺功能状态、甲状腺体积、抗 TSH 受体自身抗体)对 GO 结局的影响。
大多数患者为轻度、轻度活动的 GO,仅有 5 例患者的临床活动评分(CAS)>3。在首次和末次观察之间,CAS(p<0.0001)和 NOSPECS(p=0.01)均显著降低,时间模式类似于伦德尔曲线。即使在首次观察时 CAS>3 的患者被排除在外,这种差异仍然得到了证实。在末次观察时,50.8%的患者改善,33.8%的患者稳定,15.4%的患者中度或明显恶化。GO 的总体结局不受任何检查变量的影响。
与伦德尔的观察结果一致,未经治疗的 GO 在大多数患者中随时间自发改善,活动高峰在 13 至 24 个月之间,这可能对确定 GO 治疗的适当时机有影响。